CVS vs PGNY
CVS: CVS Health is an integrated health care giant combining extensive retail pharmacy networks, pharmacy benefits management, and comprehensive health insurance offerings to simplify consumer health experiences. PGNY: Progyny is a benefits platform that delivers superior fertility and women's health outcomes for employers through proprietary Smart Cycle treatment bundles, a selective specialist network, and integrated pharmacy services.
Side-by-side fundamentals
| Metric | CVS | PGNY | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $108.08 | $31.35 | |
| Market cap as of 2026-07-23 | $140.4B | $2.4B | |
| P/E as of 2026-07-23 | 47.90 | 35.98 | PGNY lower |
| PEG as of 2026-07-23 | 3.33 | 3.26 | PGNY lower |
| Net margin as of 2026-07-23 | +0.7% | +5.2% | PGNY higher |
| Gross margin as of 2026-07-23 | +13.9% | +24.1% | PGNY higher |
| Operating margin as of 2026-07-23 | +1.6% | +7.5% | PGNY higher |
| ROE as of 2026-07-23 | +3.9% | +13.3% | PGNY higher |
| ROA as of 2026-07-23 | +1.1% | +9.0% | PGNY higher |
| Debt / equity as of 2026-07-23 | 0.81 | 0.00 | PGNY lower |
| Revenue growth (YoY) as of 2026-07-23 | +7.6% | +6.6% | CVS higher |
| Revenue CAGR (3y) SEC XBRL | +7.6% | +17.9% | PGNY higher |
| Dividend yield as of 2026-07-23 | +2.4% | n/a | |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-07-23 | 0.59 | 1.02 | |
| 1-year return as of 2026-07-22 close | +76.9% | +40.5% | CVS higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.